FDA Grants AP Status for Piroxicam ANDA206152 by Micro Labs
The FDA has granted an Abbreviated New Drug Application (ANDA) approval status of 'AP' for Piroxicam submitted by Micro Labs.
Asset / Drug
Drug and asset intelligence for Piroxicam with 5 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
Strides Pharma has received an Abbreviated New Drug Application (ANDA) approval for Piroxicam.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.